Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Charles River Laboratories acquisition of Vigene Biosciences
We are advising Charles River on the acquisition
Accuray private exchange offers
We advised Accuray on its exchange of convertible senior notes
ImmunityBio $500 million at-the-market offering
We advised the sales agent in connection with the equity offering
Vaccitech $110.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Aveanna $458.8 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Privia Health $525.8 million IPO
We advised Privia Health on its IPO and Nasdaq listing
Roivant Sciences combination with Montes Archimedes Acquisition
We are advising Roivant Sciences on its combination with a SPAC
EDAP TMS $28 million follow-on offering
We advised the underwriters on the equity offering
Zai Lab $857.5 million offering of American depositary shares and ordinary shares
We advised Zai Lab on the concurrent offerings
NeuroPace $102 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing